Search

Search Constraints

You searched for: Author/Creator Peviani, Marco

Search Results

1. A step forward in the sigma enigma: a role for chirality in the sigma1 receptor–ligand interaction?. Issue 1 (17th October 2014)

2. An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse model. Issue 4 (6th March 2023)

3. Biodegradable polymeric nanoparticles administered in the cerebrospinal fluid: Brain biodistribution, preferential internalization in microglia and implications for cell-selective drug release. (July 2019)

4. Chemical, Pharmacological, and in vitro Metabolic Stability Studies on Enantiomerically Pure RC‐33 Compounds: Promising Neuroprotective Agents Acting as σ1 Receptor Agonists. Issue 9 (5th July 2013)

8. Studies on the Enantiomers of RC-33 as Neuroprotective Agents: Isolation, Configurational Assignment, and Preliminary Biological Profile. Issue 11 (7th September 2013)

9. Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist. (March 2016)

10. Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising Sigma1 receptor agonist. (March 2016)